CLINICAL_TRIALS
research
· 2013-07-16
Clinical Trial Update: Nitric Oxide, LPS and the Pathogenesis of Asthma Phase II [Phase 1]
Summary
The trial investigating nitric oxide and lipopolysaccharide in the pathogenesis of asthma in healthy volunteers was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: John Sundy | Conditions: Healthy | Phase 1 | Status: TERMINATED